MEETINGS - Drug Delivery Systems - Innovative Strategies to Improve Product Competitiveness (US) May 1999:
This article was originally published in Clinica
Executive Summary
IBC Conferences will hold a meeting entitled Drug Delivery Systems - Innovative Strategies to Improve Product Competitiveness in Washington, DC, on May 24-25. Topics of discussion include future technological challenges to optimise drug delivery research and development; product development opportunities with alternative drug delivery systems for chemotherapeutics; and emerging areas in the sector such as gene and cell therapy, combination products, and pro-drugs delivery. For more information contact IBC's US offices. Tel: +1 508 481 6400. Fax: +1 508 481 7911.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.